Pain News and Research

Latest Pain News and Research

September issue of JACR summarizes methods for radiation dose optimization in chest CT scans

An article in the September issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in chest computed tomography (CT) scans.

2 Sep 2011

Short-term glucocorticoid treatment may prevent osteoarthritis after joint injury

Joint injury can result in irreversible damage of cartilage which, despite treatment and surgery, often eventually leads to osteoarthritis (OA) in later life. New research published in BioMed Central's open access journal Arthritis Research & Therapy demonstrates that short term treatment of damaged cartilage with glucocorticoids can reduce long term degenerative changes and may provide hope for prevention of OA after injury.

2 Sep 2011

Ronald Reagan UCLA Medical Center receives ACCF's GWTG Gold award

Ronald Reagan UCLA Medical Center is one of only 167 hospitals nationwide to receive the American College of Cardiology Foundation's NCDR ACTION Registry-GWTG (Get with the Guidelines) Gold Performance Achievement Award for 2011.

2 Sep 2011

ACS' Commission on Cancer releases new standards to directly address patient concerns

A patient-centered approach is at the forefront of new accreditation standards for hospital cancer programs released today by the Commission on Cancer (CoC) of the American College of Surgeons.

2 Sep 2011

Obama gets tough on abortion protesters; state abortion laws challenged in courts

The Obama Justice Department has been taking a more aggressive approach against people who block access to abortion clinics, using a 1994 law to bring cases in greater numbers than its predecessor. The numbers are most stark when it comes to civil lawsuits, which seek to create buffer zones around clinic entrances for people who have blocked access in the past.

2 Sep 2011

Dr. Reddy’s initiates DRL-17822 Phase II study in type II dyslipidemia

Dr. Reddy's Laboratories announced the initiation of dosing with DRL-17822 in patients with diagnosis of type II dyslipidemia. DRL-17822 is a selective, orally bioavailable inhibitor of cholesteryl ester transfer protein (CETP), for the treatment and/or prevention of dyslipidemia, atherosclerosis and associated cardiovascular disease.

2 Sep 2011

Special journal edition chronicles 3-D structures of important antibacterial, bioterrorist targets

The September issue of the online scientific journal Acta Crystallographica: Structural Biology and Crystallization Communications (Acta Cryst F) will consist entirely of work done at the Seattle Structural Genomics Center for Infectious Disease (SSGCID), a consortium of researchers from Seattle BioMed, Emerald BioStructures, the University of Washington and Pacific Northwest National Laboratory.

2 Sep 2011

New meta-analysis reaffirms safety profile of aspirin for pain relief, fever

A new meta-analysis published this week in Drugs in R&D, reaffirms the safety profile of aspirin for short-term treatment of mild to moderate pain, and aches and fever due to colds when used as directed.

2 Sep 2011

Dendritic cells play central role in regulation of acetaminophen's toxicity

NYU School of Medicine researchers have discovered that dendritic cells in the liver have a protective role against the toxicity of acetaminophen, the widely used over-the-counter pain reliever and fever reducer for adults and children.

2 Sep 2011

Increased fat mass linked to high-intensity back pain

Increased back pain among people who are overweight or obese is specifically related to increased body fat content, reports a study in the September 15 issue of Spine.

2 Sep 2011

Medtronic initiates U.S. post-approval study of Endurant AAA Stent Graft System

Leading the development of endovascular aortic repair (EVAR), Medtronic, Inc. today announced the start of its U.S. post-approval study of the Endurant AAA Stent Graft System, a medical device used to treat abdominal aortic aneurysms.

From Medtronic 2 Sep 2011

Eclipse extends tender offer to acquire Icagen for $6.00 per share

Pfizer Inc. and Icagen, Inc. announced today that Pfizer's wholly-owned subsidiary, Eclipse Acquisition Corp., has extended the expiration date of its tender offer for all outstanding shares of common stock of Icagen for $6.00 per share, paid to the seller in cash, without interest thereon, less any applicable withholding and transfer taxes.

2 Sep 2011

Medtronic acquires PEAK and Salient

Medtronic, Inc. today announced that it has completed the acquisition of two privately-held companies, PEAK Surgical, Inc. and Salient Surgical Technologies, Inc. Both of the companies are focused on advanced energy surgical technologies and will broaden Medtronic Surgical Technologies' portfolio of innovative surgical products to meet customer and patient needs worldwide.

From Medtronic 2 Sep 2011

New guidelines for the treatment of acromegaly, a serious growth hormone disorder

It’s said a lot can happen in seven days. In seven years, a lot has happened in the understanding of acromegaly, a debilitating condition that causes a patient to have too much growth hormone. It’s seven years since the American Association of Clinical Endocrinologists last produced guidelines for the diagnosis and treatment of acromegaly. Their 2004 guidelines were just 13 pages long. Their latest, the 2011 guidelines, have grown – to 44 pages.

31 Aug 2011

Microvisk introduces unique handheld device which monitors blood clotting status

Microvisk Technologies has introduced its unique handheld devices which monitor the blood clotting status of patients to the US market. Showcased at the prestigious American Association for Clinical Chemistry annual conference, the Microvisk devices attracted strong interest from distributors and potential partners ahead of clinical trials in major US medical centres this autumn and product launches in 2012.

31 Aug 2011

New minimally invasive technique now a feasible option to treat scoliosis in teenagers

Minimally invasive surgery to treat scoliosis in teenagers is now a "feasible option," according to Vishal Sarwahi, MD, Director of Spine Deformity Surgery at Montefiore Medical Center.

31 Aug 2011

Simple tips for children's shoe shopping

As parents and children begin the back to school shopping ritual that includes fashionable shoes, the Ontario Society of Chiropodists (OSC) stresses that fit is more important than looks. Well-fitting shoes reduce the incidence of foot and ankle injuries and encourages physical activity, helping to increase self esteem through sport.

31 Aug 2011

Insight Pharmaceuticals announces acquisition of MONISTAT business from McNEIL-PPC

Insight Pharmaceuticals, a portfolio company of Swander Pace Capital, announced today that it has acquired the MONISTAT North American brand portfolio from McNEIL-PPC, Inc.

31 Aug 2011

FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation

Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.

30 Aug 2011

Stent for Life Initiative aims to support implementation of primary PCI in the ESC countries

Primary PCI is the best reperfusion therapy for patients presenting with acute ST-elevation myocardial infarction. CJ Terkelsen and co-workers used the Western Denmark Heart Registry to describe the implementation of primary PCI in Denmark.

30 Aug 2011

Pain News and Research

Latest Pain News and Research

September issue of JACR summarizes methods for radiation dose optimization in chest CT scans

Short-term glucocorticoid treatment may prevent osteoarthritis after joint injury

Ronald Reagan UCLA Medical Center receives ACCF's GWTG Gold award

ACS' Commission on Cancer releases new standards to directly address patient concerns

Obama gets tough on abortion protesters; state abortion laws challenged in courts

Dr. Reddy’s initiates DRL-17822 Phase II study in type II dyslipidemia

Special journal edition chronicles 3-D structures of important antibacterial, bioterrorist targets

New meta-analysis reaffirms safety profile of aspirin for pain relief, fever

Dendritic cells play central role in regulation of acetaminophen's toxicity

Increased fat mass linked to high-intensity back pain

Medtronic initiates U.S. post-approval study of Endurant AAA Stent Graft System

Eclipse extends tender offer to acquire Icagen for $6.00 per share

Medtronic acquires PEAK and Salient

New guidelines for the treatment of acromegaly, a serious growth hormone disorder

Microvisk introduces unique handheld device which monitors blood clotting status

New minimally invasive technique now a feasible option to treat scoliosis in teenagers

Simple tips for children's shoe shopping

Insight Pharmaceuticals announces acquisition of MONISTAT business from McNEIL-PPC

FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation

Stent for Life Initiative aims to support implementation of primary PCI in the ESC countries

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pain News and Research

Latest Pain News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in